Health & Medicine
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
A third of people with cancer red-flag symptoms did not see a GP for six months
LONDON — A troubling new picture of how Brits respond to possible cancer symptoms has emerged, with research showing that a third…
-
Cancer signs thousands overlook – ‘won’t contact GP for
LONDON, June 29 — A troubling pattern is emerging across the UK, one that families here and across Asia might recognise all…
-
Cell junction genes predict breast cancer subtype outcomes
TOKYO — A new study offers a more personal look at breast cancer, suggesting that the way cells stick together could help…
-
WHO reports 1,300 excess deaths in Europe amid record heatwave
Forty degrees Celsius in Germany, the Czech Republic and Poland. That was Sunday. One thousand three hundred excess deaths across Europe since…
-
Cell junction gene signatures predict survival in aggressive breast cancer subtypes, study finds
Researchers in Tokyo have drawn a roadmap from the lab bench to the clinic, but the journey is far from over. Their…
-
On-site training for Ethiopian health workers cuts child cancer diagnosis delays, study finds
In Northwest Ethiopia, a child with cancer waits. Too often, that wait ends badly. A new study suggests a simple fix: train…
-
Ipsen completes Kartos acquisition and adds navtemadlin to its myelofibrosis pipeline
The clinical trial is called POIESIS. More than 600 patients. Over 250 sites worldwide. It is testing navtemadlin as an add-on to…
-
Rotary Club of Uptown Kampala president targets Uganda’s chronic blood shortage
When Dr Fredrick Bakandonda took over as president of the Rotary Club of Uptown Kampala on June 27, he didn’t just inherit…
-
Ipsen to buy Kartos for up to $1.75 billion to expand myelofibrosis pipeline
Myelofibrosis patients face a grim clock. A new drug acquisition aims to change that. PARIS — For patients with a certain type…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
USF researchers find Antarctic sea squirt compound kills melanoma in mice
TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times. And one compound that killed melanoma in mice…
-
Anixa Biosciences Secures First Korean Patent for Breast Cancer Vaccine
Anixa’s Korean Patent Opens Door to Clinical Trials in Asia SAN JOSE — The patent paperwork is done. Now comes the hard…
-
Antarctic sea squirt toxin kills melanoma in mouse study
Six weeks of diving in water cold enough to kill. Depths of 130 feet. Half-hour bottom times. That was the price of…
-
Mindfulness Program Linked to Fewer Complications After Liver Cancer Procedure, Study Finds
HOUSTON, June 29 — A new study suggests that mindfulness-based stress reduction may improve perioperative outcomes for patients with advanced hepatocellular carcinoma…
-
American Heart Association Says E-Cigarette Chemicals May Harm the Heart
DALLAS, June 29 — The question “Is vaping bad for my health?” has a growing scientific answer, and it’s yes. Researchers are…
-
Meta-Analysis: Exercise Boosts Bone Density in Men Over 45
NEW YORK, June 28 — A new meta-analysis delivers a clear message for men over 45: the right kind of exercise, done…
-
Stomach Cancer Surge in Under-50s: Experts Reveal Key Risk Factors
GREENVILLE, S.C., June 28 — Carly Douglas was 34 years old, a mother of three, and an influencer with 140,000 Instagram followers.…
-
Grey Hair in Your 20s, Foggy Memory in Your 30s: What Neurologists Say About Stress
MANILA, June 28 — For many people across Asia, noticing grey hair in their twenties or struggling with memory in their thirties…
-
What’s Actually Driving Your Chronic Pain, From A Pain Psychologist
NEW YORK, June 28 — For nearly two decades, a psychologist who specializes in pain has been living with a reminder that…
-
Meta-Analysis of 12 Trials Finds Exercise Raises Spine and Femoral Neck Bone Density in Men
Men over 45 have been losing bone density for years. Most don’t know it. A new meta-analysis, released June 28, confirms that…
-
Meta-Analysis: Resistance Plus Impact Exercise Builds Spine and Femoral Neck Bone in Men Over 45
NEW YORK — A quarter of men over 50 will break a bone because their skeleton is too thin. That single number,…
-
Doctors say stress can add to grey hair and memory lapses but rarely explains them
MANILA — The mother who cannot remember where she put her keys. The young office worker spotting grey strands in the mirror.…
-
Neurologists say grey hair and memory lapses do not necessarily mean faster aging
MANILA — The grey hair in your 20s. The forgotten appointment at 35. For millions across Asia, these moments trigger a private…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992